baber/WOPTO huggingface dataset:
Patent FI-982737-A0 (FI)
Inventor: SIPILAE KAI
IPC: D21B1/02
Filed: 1998-12-17
Abstract: Raw material, energy and waste management are arranged in a production plant manufacturing pulp, paper, or board or a combination thereof from recycled fibres which is advantageously placed in the middle of a residential community or in its immediate vicinity. The plant has equipment for the manufacture of pulp and/or paper and/or board as well as equipment for the production of energy for at least the production plant's own needs. The production plant uses as fibre raw material waste paper and/or board generated by the residential community and as the source of energy combustible waste generated by the residential community. Moreover, it utilizes as far as possible waste fractions which are produced as by-products in production processes and which contain raw materials and energy either as raw material or as energy or, alternatively, these fractions are supplied outside the production plant for useful use.
Patent IL-63333-A0 (IL)
Title: Homogeneous specific binding assay device,its preparation and its use in determining a ligand
IPC: G01N21/78
Filed: 1981-07-16
Abstract: A homogeneous specific binding assay device, a method for its preparation, and a method for its use in determining a ligand, such as antigen, hapten, or antibody, in, or the ligand binding capacity of, a liquid sample. The test device comprises a solid carrier member, such as a fibrous web matrix, e.g., paper, or a polymeric film or gel, incorporated with reagents for a homogeneous specific binding assay system which produces a detectable response, usually an electromagnetic radiation signal, that is a function of the presence or amount of the ligand in or the ligand binding capacity of the sample. Useful homogeneous specific binding assay systems include those involving enzyme substrate labels, enzyme prosthetic group labels, and enzyme labels. The detectable response preferably is a luminescent, fluorescent, spectrophotometric, or colorimetric response, which is measurable by visual observation or instrument means.
Patent IL-70716-A0 (IL)
Title: Method of making parallel programming or field programming of electronic matrix arrays
IPC: H01L45/00
Filed: 1984-01-18
Abstract: A method of making a parallel programmed electronic matrix array includes forming at least one layer of a phase changeable material on a conductive substrate, the material preferably formed of amorphous material and having substantially nonconductive and comparatively high conductive states, and irradiating selected areas of the layer to convert them to the other state. Thereafter, in a preprogrammed embodiment, first and second sets of electrically conductive address lines are formed on respective opposite sides of the layer such that they cross each other at an angle to form a plurality of crossover points. In a field programmable array, the selected areas are irradiated through one set of lines.In accordance with another embodiment, the selected areas are irradiated through a mask. One set of lines is preferably formed by removing portions of the conductive substrate. The other can be formed by detecting the locations of the layer portions of one of the states and aligning the lines on the layer according to such detection.A diode structure can be formed with or in place of the phase changeable material.
Patent IL-80816-A0 (IL)
Title: Process for the preparation of cefodizime
IPC: C07D/
Filed: 1986-12-01
Abstract: A process for the preparation of cefodizime of the formula   <IMAGE> +TR   <IMAGE>  wherein (a) a compound of the formula II (ATS) <IMAGE>   wherein R1 represents hydrogen or an aminoprotective group and A represents a hydrogen atom or one equivalent of an alkali metal or alkaline earth metal, of ammonium or of an organic nitrogen base, is first reacted with a compound of the formula III R-SO2Hal  wherein R represents an optionally substituted alkyl, aryl or aralkyl radical and Hal represents a halogen atom, in an organic solvent and, if appropriate, in the presence of a base, (b) a compound of the formula I (TACS)   <IMAGE>    in which A has the above meaning, is reacted with a silylating agent in an organic solvent and, if appropriate, in the presence of a base, and (c) the two products formed in (a) and (b) are reacted in their reaction solutions, and any protective group R1 present in the end product of the formula I is eliminated.
Patent IL-83364-A0 (IL)
Title: Substituted 5-amino-1-phenylpyrazoles
IPC: C07C255/66
Filed: 1987-07-28
Abstract: A 5-aminopyrazole of the formula   <IMAGE>    in which R1 represents alkoxycarbonyl, alkenyloxycarbonyl or alkinyloxycarbonyl, and R3, R4, R5, R6, and R7, which are identical or different, represent hydrogen, halogen, cyano, nitro, alkyl, alkoxy, alkylsulphonyl, alkoxycarbonyl or a radical -(X)n-R8  wherein X represents oxygen, sulphur, sulphinyl or sulphyonyl, n represents 0 or 1 and R8 represents halogenoalkyl, with the proviso that at least one of the radicals R3, R4, R5, R6 or R7 represents a radical -(X)n-R8, and R1 does not represent cyano if R1 represents trifluoromethyl, These compounds are intermediates useful in the preparation of herbicidally active substituted 5-acylamino-1-phenylpyrazoles.
Patent IL-90780-A0 (IL)
Title: Gap gene sequences and diagnostic uses thereof
IPC: G01N33/573
Filed: 1989-06-29
Abstract: The invention provides a method for identifying cancer therapeutics, comprising the steps of: (a) combining in a GAP assay compatible solution a compound suspected of being a cancer therapeutic, ras p21 protein having GAP stimulatable GTPase activity, and labelled GTP, the GAP optionally having a reduced molecular weight of about 115,000-120,000 daltons or the GAP comprising a molecule having a reduced molecular weight of about 45-55,000 daltons and being a fragment derived from a molecule having a reduced molecular weight of about 115,000-120,000 daltons; (b) measuring the amount of GTP converted to GDP plus phosphate; and (c) relating the amount of GTP converted to GDP with a control sample prepared in accordance with step "a", said control sample being known to be free of said suspected cancer therapeutic.
Patent IL-98836-A0 (IL)
Title: Tablet and granulate containing mesna as active substance
IPC: A61K31/185
Filed: 1991-07-15
Abstract: A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other agents. The tablets contain: 0.01-1 parts by weight of a binding agent 0.03-0.4 parts by weight of a disintegrant 0.01-0.2 parts by weight of a lubricant and 0.1-1 parts by weight of a filling agent as well as, in the case of an effervescent tablet, an additional 0.05-30 parts by weight of a conventional physiologically acceptable effervescent mixture.
Patent FI-20020090-A0 (FI)
Inventor: SUNDHOLM G RAN
IPC: A62C35/08
Filed: 2002-01-17
Abstract: A valve element ( 20 ), comprising a frame ( 21 ), at least one first inlet ( 26 ), at least one second inlet ( 27 ) and at least one outlet ( 28 ). The valve element consists of a combination comprising at least one burst disk ( 23 ) or equivalent, which, when unbroken, closes a passage from the second inlet ( 27 ) at least to the outlet ( 28 ), and a piston element ( 25 ) comprising a piercing element ( 24 ) or the like for piercing the burst disk, said piston element being arranged to be movable between at least two positions when the burst disk has been pierced, in which first position the passage from the second inlet ( 27 ) to the outlet ( 28 ) is closed while in a second position the passage from the second inlet ( 27 ) to the outlet ( 28 ) is open, to which second position the piston element is moved after the pressure difference between the second inlet and the first inlet has reached a predetermined value.
Patent IL-109578-A0 (IL)
Title: Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
IPC: C07J41/00
Filed: 1994-05-06
Abstract: nor-Bile acid derivatives of the formula I  G1 - X - G2      I, in which G1, G2 and X have the stated meanings, processes for preparing these compounds and medicines are described. On the basis of their pharmacological action, they can be used as antihyperlipidaemic.
Patent IL-115303-A0 (IL)
Title: Launching projectiles
IPC: B64F1/06
Filed: 1995-09-14
Abstract: A collapsing vacuum behind the piston of a piston and cylinder arrangement may be used to provide a forward propelling force to launch a projectile such as an RPV or VAV. Apparatus for launching an unmanned air vehicle or other projectile may comprise a tension gas spring consisting of a cooperating piston 108 and cylinder 110 arrangement in which at least a partial vacuum may be created behind the piston 108, a tension element (rope) coupled to the piston and a releasable coupling (e.g. trolley) for interconnecting the tension element and the vehicle or other projectile and adapted to be released at launch velocity, whereby collapse of said vacuum is effective to apply a forward propelling force to the projectile via the tension element. The vacuum may be generated between the piston 108 and a contra-piston 208, actuated by a winch 113. <IMAGE>
Patent IL-136316-A0 (IL)
Title: Improvements in or relating to motor linkages
IPC: F16H21/10
Filed: 2000-05-23
Abstract: An articulated linkage mechanism 10 comprises a motor 11 arranged to produce a torque force on a drive shaft 12. A crank 13 is mounted to the drive shaft 12 at a first mounting position 14 located at a first end 15 of the crank 13. A second mounting position 16 at a second end 17 of the crank 13 is attached to a link 18 at a first end 20 of the link 18. At a second mounting position 21 on the link 18 at a second end 22, which is remote from the first end 20, a load, not illustrated, is attached. At an intermediate pivot mounting position 23 of the link 18, an arm 26 is attached and a remote end 30 of the arm 26 is fixed to an anchorage position 31. The motor 11 is fixed and the second mounting position 29 of the arm 26 is fixed with respect to the first mounting position 14 of the crank 13. The movement of the link 18 is constrained by the arm 26 such that the crank 13 is able to rotate through a range of angles greater than +/- 270 DEG . <IMAGE>
Patent IL-138589-A0 (IL)
Title: Anti-tumour agents
IPC: A61K31/215
Filed: 1999-03-16
Abstract: The invention concerns anti-tumour agents of formula (I) wherein each of R1, R2 and R3 has the meanings defined in the specification including hydrogen, (1-4C)alkyl, (3-4)alkenyl, (3-4C)alkynyl, amino, (1-4C)alkylamino and (1-4C)alkoxy; each of R4 and R5 is (1-4C)alkyl; each of R6 and R7 is hydrogen or (1-4C)alkyl; X is oxygen; m is 1 or 2 and each R8 is as defined in the specification; each of Y1 and Y2 is halogeno, (1-4C)alkanesulphonyloxy, benzenesulphonyloxy or phenyl-(1-4C)akanesulphonyloxy; or a pharmaceutically-acceptable salt thereof; provided that at least one of R1, R2 and R3 is other than hydrogen; a process for preparation, pharmaceutical compositions containing them and their use in the production of an anti-proliferative effect.
Patent IL-142409-A0 (IL)
Title: Magnetic field applicator for heating magnetic or magnetizable substances or solids in biological tissue
IPC: H01F7/20
Filed: 2000-07-18
Abstract: A magnetic field applicator to heat magnetic substances in biological tissue, having a magnetic yoke with two pole shoes across from each other and separated from each other by a distance that defines the magnetic field exposure volume produced by the applicator, and with two magnetic coils, one assigned to each of the two pole shoes, to produce a magnetic field. The magnetic yoke and the pole shoes consist of ferrite segments assembled together. The pole shoes oppose each other and are surrounded by magnetic disk-shaped coils with one or more windings extending helicoidally, which creates an intermediate air gap between the pole shoes and coils. This results in a magnetic field applicator with the ability to effectively and efficiently administer hyperthermia and thermo-ablation procedures to destroy cancerous tissue in a patient, as well as having uses in other medical and industrial applications.
Patent IL-144372-A0 (IL)
Title: Oils with heterogeneous chain lengths
IPC: C10M137/10
Filed: 2000-01-19
Abstract: Oils containing a triacylglycerol polyol ester and a non-glycerol polyol ester are described, as well as methods of making such oils. Methods for improving lubrication properties of a vegetable oil also are described.
Patent IL-149243-A0 (IL)
Title: Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same
IPC: A61P25/00
Filed: 2000-05-25
Abstract: Tetrapeptide L-alanyl-L-glutamyl-L-asparagyl-L-proline of the general formula L-Ala-L-Glu-Asp-L-Pro is proposed as a biologically active compound stimulating the functional activity of neurones. The application of L-Ala-L-Glu-L-Asp-L-Pro tetrapeptide in medicine is proposed for the preparation of a drug stimulating the functional activity of neurones. There is proposed a pharmacological agent, which contains as its active base an effective amount of L-Ala-L-Glu-L-Asp-L-Pro tetrapeptide for its salts of the amino acid group (acetate, hydrochloride, oxalate) or its salts of carboxyl groups (the salts of sodium, potassium, calcium, lithium, zinc, magnesium, and also the salts of organic and inorganic cations-ammonium, triethylammonium). The agent is proposed for parenteral, intranasal and oral administration. In accordance with the invention, the method of stimulating the functional activity of neurones consists in preventive and/or therapeutic administration to the patient of the pharmacological agent in doses 0.01 to 100 mug/kg of the body weight at least one a day for a period necessary for attaining a therapeutic effect.
Patent IL-155190-A0 (IL)
Title: Lead free powdered metal projectiles
IPC: F42B12/74
Filed: 2001-10-09
Abstract: Lead free projectiles having a density less than lead, including preferred embodiments comprising a low ductility metal powder and a high ductility metal powder.
Patent IL-156361-A0 (IL)
Title: Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity
IPC: A61P29/00
Filed: 2001-12-19
Abstract: A novel pharmaceutical composition is provided by which nonsteroidal anti-inflammatory drugs (NSAIDs) are added directly to phospholipid-containing oil such as lecithin oils or to a bio-compatible oil to which an phospholipid has been added to make a NSAID-containing formulation that possess low gastrointestinal (GI) toxicity and enhanced therapeutic activity to treat or prevent inflammation, pain, fever, platelet aggregation, tissue ulcerations and/or other tissue disorders. The composition of the invention are in the form of a non-aqueous solution, paste, suspension, dispersion, colloidal suspension or in the form of an aqueous emulsion or microemulstion for internal, oral, direct or topical administration.
Patent IL-164011-A0 (IL)
Title: Antagonistic anti-hfas ligand human antibodies andfragments thereof
IPC: C07K16/28
Filed: 2003-03-12
Abstract: Human antibodies, preferably recombinant human antibodies that specifically bind to human Fas Ligand (hFasL) are disclosed. These antibodies have high affinity for hFasL, a slow off rate for hFasL dissociation and neutralize a Fas Ligand activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antigen-binding portions, of the invention are useful for neutralizing Fas Ligand activity, e.g., in a human subject suffering from a disorder in which hFas Ligand activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant anti-hFasL human antibodies, and the methods for synthesizing the recombinant human antibodies are also encompassed by the invention.
Patent IL-166466-A0 (IL)
Title: Methods for the treatment of dementia based on apoe genotype
IPC: G01N33/68
Filed: 2005-01-24
Abstract: This invention relates to methods to prevent worsening of and/or to improve cognitive functioning and behavior problems in patients with dementia by means of ApoE genotyping to guide the use of AChEI drugs, including rivastigimine. Also included are kits for determining ApoE4 status and recommended treatment strategy.
Patent IL-183128-A0 (IL)
Title: Tampo applicator
Filed: 2007-05-10
Abstract: A tampon applicator having an outer member adapted to house a tampon and receive an inner member. The outer member includes a fingergrip region having an indentation region that extends inwardly from the outer surface of the outer member. The indentation region has a depth dimension that is measured from the outer surface of the outer member to a lowest point of the indentation region. The indentation region comprises a first raised portion and a second raised portion, each of which having a height dimension that is measured from an individual raised portion's base to an individual raised portion's highest point, wherein the height dimension is less than the depth dimension. The first raised portion is a different size and a different shape as compared to the second raised portion.
Patent IL-183875-A0 (IL)
Title: Adhesive composition based on ethylene copolymers, useful for extrusion-coating and extrusion-lamination of a variety of supports
Filed: 2007-06-12
Abstract: The invention concerns an adhesive composition consisting of at least one ethylene polymer or copolymer, said composition comprising at least one unsaturated carboxylic acid ester comonomer, and at least one functional comonomer, useful in an extrusion-coating process for application on a support or in an extrusion-lamination process for bonding together several supports of different type or not, in a wide temperature range. The invention is characterized in that said composition has an unsaturated carboxylic acid ester content higher than 5 wt % and in that the functional comonomer consists of at least one reactive function in the form of an acid group, anhydride or epoxy, whereof the proportion is less than 1 wt % of the composition. Said composition has advantageous uses, in particular for bonding together substrates selected among aluminum, paper or cardboard, cellophane, films based of polyethylene, polypropylene, polyamide, polyester, polyvinyl chloride (PVC), polyvinylidene chloride (PVDC), polyacrylonitrile (PAN) resins, oriented or not, metal-coated or not, physically or chemically treated or not and films coated with a thin inorganic barrier layer, such as polyester (PET, SiOx or AlOx).
Patent IL-185152-A0 (IL)
Title: Systems and methods for managing information relating to medical fluids and containers therefor
IPC: G16H10/60
Filed: 2007-08-09
Abstract: The present invention relates to management of information relating to medical fluids, containers therefor, and medical fluid administration devices for administering such medical fluids to patients. Data tags (e.g., RFID tag) are generally associated with containers of the invention and may be electromagnetically read from and/or written to using an electromagnetic device, for example, that may be associated with a medical fluid administration device of the invention.
Patent IL-188143-A0 (IL)
Title: Use of modified pore-forming proteins for the preparation of a medicament for treating or preventing benign prostatic hyperplasia
Filed: 2007-12-13
Abstract: The present invention provides a method of treating BPH using modified pore-forming proteins (MPPs). These MPPs are derived from naturally occurring cytotoxic proteins (nPPs) that kill cells by forming pores or channels in the cell membrane, resulting in cell death. The MPPs are generated by modification of the nPPs such that they are capable of being selectively activated at normal prostate cells. Such modification may include the addition of a prostate-specific protease cleavage site to the activation sequence, and/or the addition of a prostate-specific targeting domain to allow selective targeting of prostate cells. These MPPs are capable of selectively targeting and killing normal prostate cells in vivo. The MPPs may be used either alone or in combination with other therapies for the treatment of BPH.
Patent IL-189994-A0 (IL)
Title: Production and purification of il-29
Filed: 2008-03-06
Abstract: The expression vectors and methods using an E. coli expression system for the large scale production of IL-29 are described. The vectors utilize the IL-29 coding sequence with specific changes in nucleotides in order to optimize codons and mRNA secondary structure for translation in E. coli. Also included are methods of producing, purifying and pegylating an IL-29 polypeptide.
Patent IL-191153-A0 (IL)
Title: Modified colorants and inkjet ink compositions comprising modified colorants
IPC: C09D7/62
Filed: 2008-04-29
Abstract: The present invention relates to a modified colorant comprising a colorant having attached at least one organic group. Various embodiments of the organic group are disclosed. For each of these embodiments, preferably the organic group has a defined calcium index value. Also disclosed are various uses for these modified colorants, including inkjet ink compositions.
Patent IL-195084-A0 (IL)
Title: Process of controlled nuclear fusion
Filed: 2008-11-03
Abstract: The invention comprises a process of controlled nuclear fusion of deuterium atoms carried out in a combustion chamber, after the combustion of a gaseous fuel which comprises deuterium atoms in the presence of an oxidation gas and a gaseous catalyst, under a positive pressure. The invention also comprises a reactor for controlled nuclear fusion to carry out the disclosed process, thus as the internal-combustion engine which comprises the reactor for controlled nuclear fusion and a vehicle which comprises said internal-combustion engine.
Patent RO-129011-A0 (RO)
Title: Installation for producing and bottling medical breathable air into cylinders to be used in diving, named oxiscaf-a
Inventor: MANDRULEANU CONSTANTIN
IPC: F04C2/24
Filed: 2013-06-14
Abstract: The invention relates to an installation for producing and bottling medical breathable air into cylinders to be used in diving. According to the invention, the installation consists of a compressor (1) providing medical air, a medical air storing reservoir (2) provided with a pressure gauge, which is coupled to a pressure step-up compressor (3) which increases the pressure up to 150 bar and stores the medical air, by means of a ramp with insulating valves and pressure gauge, in four cylinders (4) to be charged with medical breathable air.
Patent RO-134132-A0 (RO)
Title: Alloy of co-cr type alloyed with ruthenium and other noble metals, for metal-ceramic dental prostheses
Inventor: ANTONIAC VASILE IULIAN
IPC: C22C38/10
Filed: 2019-12-23
Abstract: The invention relates to a CoCrMN type alloy, where MN are noble metals Ru, Zr and Ag, obtained by elaboration in an arc electric furnace, in neutral atmosphere, with or without magnetic levitation, the alloy with a high biocompatibility being used in dental applications, namely for manufacturing metal-ceramic prostheses. According to the invention, the alloy has the following chemical composition expressed as percentage by mass: 58 ... 61% Co, 28 ... 30% Cr, 3.4 ... 4.4% Si, 2 ... 4% Ru, 0.7 ... 1.4% Zr and 0.8 ... 1.2% Ag.